Expanded Studies on the SCAPIS Stockholm Reexamination Cohort
The Swedish CArdioPulmonary bioImage Study (SCAPIS) is a unique, large-scale national research initiative involving 30,000 randomly selected individuals aged 50-64, recruited between 2014 and 2018. The study is a collaborative effort among six university hospitals across Sweden. A follow-up study, SCAPIS 2, is conducte
| Condition(s) | Coronary Artery Disease, Arterial Stiffness, Blood Pressure, AORTIC VALVE DISEASES, Mitral Valve Stenosis and/or Insufficiency, Heart Failure, Pulmonary Disease, Chronic Obstructive (COPD), Steatohepa |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The Swedish CArdioPulmonary bioImage Study (SCAPIS) is a unique, large-scale national research initiative involving 30,000 randomly selected individuals aged 50-64, recruited between 2014 and 2018. The study is a collaborative effort among six university hospitals across Sweden. A follow-up study, SCAPIS 2, is conducted for half of the original participants. In Stockholm, 2,500 individuals will be re-examined at Danderyd University Hospital and Karolinska Institutet. SCAPIS 2 includes a core set of examinations involving blood sampling, questionnaires, and imaging. In addition to these, complementary local investigations are conducted to enable more detailed research questions. This protocol describes the additional studies conducted in the Stockholm cohort. All complementary assessments a |
| Who can participate | Inclusion Criteria: Subjects already included in the main / general SCAPIS reexamination study in Stockholm. Exclusion Criteria: Inability to provide consent. |
| Ages | 56 Years to 74 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Danderyd Hospital |
| Locations | Stockholm, Sweden |
| Start date | 2024-04-08 |
| NCT ID | NCT07476703 |
| Official listing | https://clinicaltrials.gov/study/NCT07476703 |